Free Trial

Marshall Wace LLP Increases Position in Cross Country Healthcare, Inc. (NASDAQ:CCRN)

Cross Country Healthcare logo with Business Services background

Marshall Wace LLP lifted its holdings in Cross Country Healthcare, Inc. (NASDAQ:CCRN - Free Report) by 714.8% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 93,543 shares of the business services provider's stock after purchasing an additional 82,063 shares during the period. Marshall Wace LLP owned approximately 0.29% of Cross Country Healthcare worth $1,699,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in CCRN. Barclays PLC increased its stake in shares of Cross Country Healthcare by 117.5% during the third quarter. Barclays PLC now owns 80,277 shares of the business services provider's stock worth $1,078,000 after buying an additional 43,372 shares during the period. Amundi grew its holdings in Cross Country Healthcare by 385.4% during the 4th quarter. Amundi now owns 26,494 shares of the business services provider's stock worth $483,000 after acquiring an additional 21,036 shares in the last quarter. Yakira Capital Management Inc. purchased a new stake in shares of Cross Country Healthcare in the 4th quarter valued at approximately $1,013,000. Chicago Capital Management LLC acquired a new stake in shares of Cross Country Healthcare in the 4th quarter valued at $7,300,000. Finally, Sei Investments Co. lifted its position in shares of Cross Country Healthcare by 7.3% during the 4th quarter. Sei Investments Co. now owns 143,380 shares of the business services provider's stock worth $2,604,000 after purchasing an additional 9,816 shares during the last quarter. 96.03% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

CCRN has been the topic of a number of analyst reports. JMP Securities restated a "market perform" rating on shares of Cross Country Healthcare in a research note on Thursday, February 6th. Barrington Research reiterated a "market perform" rating and issued a $18.61 price objective on shares of Cross Country Healthcare in a report on Friday, March 14th. Finally, StockNews.com initiated coverage on Cross Country Healthcare in a research note on Tuesday, April 29th. They set a "hold" rating for the company. Six equities research analysts have rated the stock with a hold rating, Based on data from MarketBeat.com, the company has an average rating of "Hold" and an average price target of $18.41.

Check Out Our Latest Stock Analysis on CCRN

Cross Country Healthcare Stock Performance

Shares of CCRN stock traded up $0.08 during mid-day trading on Friday, hitting $13.61. 167,388 shares of the stock were exchanged, compared to its average volume of 594,263. The stock's fifty day simple moving average is $14.94 and its two-hundred day simple moving average is $15.39. Cross Country Healthcare, Inc. has a 12-month low of $9.58 and a 12-month high of $18.50. The stock has a market capitalization of $446.22 million, a price-to-earnings ratio of -272.15, a P/E/G ratio of 3.32 and a beta of 0.25.

Cross Country Healthcare Profile

(Free Report)

Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.

Recommended Stories

Institutional Ownership by Quarter for Cross Country Healthcare (NASDAQ:CCRN)

Should You Invest $1,000 in Cross Country Healthcare Right Now?

Before you consider Cross Country Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cross Country Healthcare wasn't on the list.

While Cross Country Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings Preview: HUGE Stock Move Ahead
These 5 Small Stocks Could Deliver Huge Returns
ACT FAST! Congress Is POURING Into This Stock

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines